Publications en collaboration avec des chercheurs de University of Cagliari (14)

2021

  1. Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?

    Frontiers in Neuroscience, Vol. 15

2017

  1. BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats

    Experimental Neurology, Vol. 297, pp. 73-81

  2. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease

    Experimental Neurology, Vol. 291, pp. 1-7

2016

  1. Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease

    Movement Disorders, Vol. 31, Núm. 4, pp. 501-511

  2. Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms

    Neurobiology of Disease, Vol. 86, pp. 140-153

2015

  1. Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats

    Behavioural Brain Research, Vol. 292, pp. 300-304

  2. Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease

    Neuroscience, Vol. 298, pp. 389-396

  3. Foetal cell transplantation for Parkinson's disease: Focus on graft-induced dyskinesia

    Parkinson's Disease, Vol. 2015

  4. How demanding is the brain on a reversal task under day and night conditions?

    Neuroscience Letters, Vol. 600, pp. 153-157

  5. The measurement invariance of schizotypy in Europe

    European Psychiatry, Vol. 30, Núm. 7, pp. 837-844

2014

  1. Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease

    Neuroscience, Vol. 265, pp. 245-252

  2. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation

    Neurobiology of Disease, Vol. 62, pp. 233-240

  3. The serotonergic system in levodopa-induced dyskinesia

    Levodopa-Induced Dyskinesia in Parkinson's Disease (Springer-Verlag London Ltd), pp. 199-212

2013

  1. 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model

    Neurobiology of Disease, Vol. 60, pp. 108-114